A drug containing 7 - [4 - (4-benzo [b] tiofen-4-il-piperazin-1-il] Butox] - 1h-quinolin-2-ona or one of the salts, and (II) at least one specific drug, comprising an emotional stabilizer, a serotonin reabsorption inhibitor, a norepinefrine reabsorption inhibitor, an inhibitor, an inhibitor A specific norepinephrine antidepressant, an anxiolytic, a tricyclic antidepressant, a tetracyclic antidepressant, an antipsychotic and an ADHD drug, combined with requirement 5: a drug that meets requirement 4,It is characterized by that the mood stabilizer is at least a specific lithium drug, sodium cholate, divalproex sodium, aminobenzene, oxcarbazepina, zonisamida, lamotrigina, topiramato, gabprenina, levotiracetam, clonazepam, fenitoyan, pregabina, thyroid hormone, tigabina, Grasso omega-3 and its salts. Claim 7: the drug referred to in claim 6, which is characterized in that the serum compound inhibitor is at least one drug selected from the group, including fluxetin, citalopram, fluvoxamina, Paroxetin, sertrarina,Estitalopram and his salt Claim 8: the drug complies with any one of the requirements of items 1 to 3, and is characterized in that the (II) drug is a Nordic reabsorption inhibitor. Claim 11: the drug referred to in claim 10 is characterized in that the reabsorption inhibitor of serum tunning and adrenaline is at least one drug selected from the group, including fenlafaxine, durocidine, medroxyprogesterone, desulfuration and its salts. Requirement 13: drugs complying with requirement 12,It is characterized by that the specific norepinephrine antidepressant is at least a specific drug composed of mirex and its salts. Claim 14: any drug referred to in claims 1 to 3, which is characterized in that the (II) drug is an anti anxiety drug. Requirement 15: drugs meeting the requirements of item 14,It is characterized by that the antianxiety drug is at least one specific drug in the group, including the antianxiety drug of benzodiazepine and the antianxiety drug of 5-HT1A
